| 来源类型 | Working Paper |
| 规范类型 | 报告 |
| DOI | 10.3386/w17174 |
| 来源ID | Working Paper 17174 |
| Pharmaceutical Pricing in Emerging Markets: Effects of Income, Competition and Procurement | |
| Patricia M. Danzon; Andrew W. Mulcahy; Adrian K. Towse | |
| 发表日期 | 2011-06-29 |
| 出版年 | 2011 |
| 语种 | 英语 |
| 摘要 | This paper analyzes determinants of ex-manufacturer prices for originator and generic drugs across a large sample of countries. We focus on drugs to treat HIV/AIDS, TB and malaria in middle and low income countries (MLICs), with robustness checks to other therapeutic categories and other countries. We examine effects of per capita income, income dispersion, number and type of therapeutic and generic competitors, and whether the drugs are sold to retail pharmacies vs. tendered procurement by NGOs. |
| 主题 | Health, Education, and Welfare ; Health ; Industrial Organization ; Market Structure and Firm Performance ; Development and Growth ; Development |
| URL | https://www.nber.org/papers/w17174 |
| 来源智库 | National Bureau of Economic Research (United States) |
| 引用统计 | |
| 资源类型 | 智库出版物 |
| 条目标识符 | http://119.78.100.153/handle/2XGU8XDN/574849 |
| 推荐引用方式 GB/T 7714 | Patricia M. Danzon,Andrew W. Mulcahy,Adrian K. Towse. Pharmaceutical Pricing in Emerging Markets: Effects of Income, Competition and Procurement. 2011. |
| 条目包含的文件 | ||||||
| 文件名称/大小 | 资源类型 | 版本类型 | 开放类型 | 使用许可 | ||
| w17174.pdf（247KB） | 智库出版物 | 限制开放 | CC BY-NC-SA | 浏览 | ||
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
